T1	Participants 302 390	patients with syncope who are at intermediate risk for an adverse cardiovascular outcome
T2	Participants 759 832	One hundred three consecutive patients (53 women; mean age 64+/-17 years)
T3	Participants 1637 1663	intermediate-risk patients
T4	Participants 94 101	syncope
